These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7616602)

  • 21. Serum gastrin concentrations in colorectal cancer patients.
    Charnley RM; Thomas WM; Stanley J; Morris DL
    Ann R Coll Surg Engl; 1992 Mar; 74(2):138-40; discussion 141. PubMed ID: 1567134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Adjuvant intra-arterial chemotherapy with gastrin receptor antagonist after hepatic resection in colorectal cancer metastasis].
    Kameyama M; Murata K; Tsugawa T; Yasuda T; Nakano H; Ohigashi H; Hiratsuka M; Sasaki Y; Kabuto T; Ishikawa O; Furukawa H; Imaoka S
    Gan To Kagaku Ryoho; 1998 Jul; 25(9):1385-7. PubMed ID: 9703835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum gastrin levels and colorectal neoplasia.
    Elewaut A; Vanderstraeten E
    Gastroenterology; 1995 Feb; 108(2):618-9. PubMed ID: 7695754
    [No Abstract]   [Full Text] [Related]  

  • 24. Predictive value of serum biomarkers in patients after portal vein embolization (PVE): a pilot study.
    Treska V; Topolcan O; Vrzalova J; Skalicky T; Sutnar A; Liska V; Fichtl J; Narsanska A; Ferda J; Treskova I; Mirka H; Kreuzberg B
    Anticancer Res; 2011 Jan; 31(1):339-44. PubMed ID: 21273621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis.
    Wu Y; Li C; Zhao J; Yang L; Liu F; Zheng H; Wang Z; Xu Y
    World J Surg Oncol; 2016 Nov; 14(1):289. PubMed ID: 27852294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum gastrin levels in patients with colorectal cancer and adenomatous polyps: a prospective study.
    Mihas AA; Maliakkal RJ; Shueke M; Achord JL
    Res Commun Mol Pathol Pharmacol; 1995 Nov; 90(2):301-4. PubMed ID: 8747797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multimarker panel for circulating tumor cells detection predicts patient outcome and therapy response in metastatic colorectal cancer.
    Barbazán J; Muinelo-Romay L; Vieito M; Candamio S; Díaz-López A; Cano A; Gómez-Tato A; Casares de Cal Mde L; Abal M; López-López R
    Int J Cancer; 2014 Dec; 135(11):2633-43. PubMed ID: 24752533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of circulating gastrin in colorectal adenomas and carcinomas.
    Lamberts R; Wartenberg T; Creutzfeldt W
    Digestion; 1999; 60(2):101-9. PubMed ID: 10095150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma levels of progastrin but not amidated gastrin or glycine extended gastrin are elevated in patients with colorectal carcinoma.
    Siddheshwar RK; Gray JC; Kelly SB
    Gut; 2001 Jan; 48(1):47-52. PubMed ID: 11115822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type IV collagen as a tumour marker for colorectal liver metastases.
    Nyström H; Naredi P; Hafström L; Sund M
    Eur J Surg Oncol; 2011 Jul; 37(7):611-7. PubMed ID: 21620632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy.
    Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H
    Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastrin and colorectal cancer. Evidence against an association.
    Yapp R; Modlin IM; Kumar RR; Binder HJ; Dubrow R
    Dig Dis Sci; 1992 Apr; 37(4):481-4. PubMed ID: 1551333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastrin and colorectal neoplasia: cause and effect.
    Niv Y
    Digestion; 2006; 74(1):40-1. PubMed ID: 17068396
    [No Abstract]   [Full Text] [Related]  

  • 34. Prognostic value of circulating endothelial cells in metastatic colorectal cancer.
    Rahbari NN; Schölch S; Bork U; Kahlert C; Schneider M; Rahbari M; Büchler MW; Weitz J; Reissfelder C
    Oncotarget; 2017 Jun; 8(23):37491-37501. PubMed ID: 28415583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrophage inflammatory protein-3 alpha (MIP-3a) is a novel serum prognostic marker in patients with colorectal cancer.
    Iwata T; Tanaka K; Inoue Y; Toiyama Y; Hiro J; Fujikawa H; Okugawa Y; Uchida K; Mohri Y; Kusunoki M
    J Surg Oncol; 2013 Feb; 107(2):160-6. PubMed ID: 22926691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating form of human vascular adhesion protein-1 (VAP-1): decreased serum levels in progression of colorectal cancer and predictive marker of lymphatic and hepatic metastasis.
    Toiyama Y; Miki C; Inoue Y; Kawamoto A; Kusunoki M
    J Surg Oncol; 2009 May; 99(6):368-72. PubMed ID: 19204971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in plasma gastrin, CEA, and CA 19-9 concentration in patients with proximal and distal colorectal cancer.
    Bombski G; Gasiorowska A; Orszulak-Michalak D; Neneman B; Kotynia J; Strzelczyk J; Janiak A; Malecka-Panas E
    Int J Gastrointest Cancer; 2002; 31(1-3):155-63. PubMed ID: 12622427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating gastrin and ghrelin levels in patients with colorectal cancer: correlation with tumour stage, Helicobacter pylori infection and BMI.
    D'Onghia V; Leoncini R; Carli R; Santoro A; Giglioni S; Sorbellini F; Marzocca G; Bernini A; Campagna S; Marinello E; Vannoni D
    Biomed Pharmacother; 2007; 61(2-3):137-41. PubMed ID: 17258885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive molecular markers for colorectal cancer patients with resected liver metastasis and adjuvant chemotherapy.
    Lassmann S; Tang L; Capanu M; Brabletz T; Schöpflin A; Zur Hausen A; Gonen M; Kemeny N; Shia J; Klimstra D; Werner M
    Gastroenterology; 2007 Dec; 133(6):1831-9. PubMed ID: 18054556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating Levels of VEGF and CXCL1 Are Predictive of Metastatic Organotropismin in Patients with Colorectal Cancer.
    Divella R; Daniele A; DE Luca R; Simone M; Naglieri E; Savino E; Abbate I; Gadaleta CD; Ranieri G
    Anticancer Res; 2017 Sep; 37(9):4867-4871. PubMed ID: 28870907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.